Search

Your search keyword '"Kaseb, A."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Kaseb, A." Remove constraint Author: "Kaseb, A." Publisher dove medical press Remove constraint Publisher: dove medical press
29 results on '"Kaseb, A."'

Search Results

1. A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements

2. Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

3. Maternal Perception, Hesitancy, and Satisfaction Toward Childhood Immunization in Primary Health Centers, Hafr Al-Batin: A Multicenter Cross-Sectional Study from Eastern Saudi Arabia

4. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma

5. Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma

6. Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

7. The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

8. A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma

9. Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma

10. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

11. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

12. Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

13. Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging

14. Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

15. Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

16. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

17. Editorial: charting the future of hepatocellular carcinoma publications

18. Minimally invasive image-guided therapies for hepatocellular carcinoma

19. Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

20. Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

21. Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

22. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

23. Welcome to Journal of Hepatocellular Carcinoma

24. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

25. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

26. Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

27. Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

28. Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives

29. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Catalog

Books, media, physical & digital resources